Malta - enska - Medicines Authority

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - syrup - lacosamide 10 mg/ml - antiepileptics

Ísrael - enska - Ministry of Health

cts ltd - lacosamide 10 mg / 1 ml - solution for infusion - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.vimpat solution for infusion is an alternative for patients when oral administration is temporary not feasible.

Singapúr - enska - HSA (Health Sciences Authority)

orient europharma pte ltd - lacosamide - tablet, film coated - 100.00 mg

Singapúr - enska - HSA (Health Sciences Authority)

orient europharma pte ltd - lacosamide - tablet, film coated - 150.00 mg

Singapúr - enska - HSA (Health Sciences Authority)

orient europharma pte ltd - lacosamide - tablet, film coated - 200.00 mg

Singapúr - enska - HSA (Health Sciences Authority)

orient europharma pte ltd - lacosamide - tablet, film coated - 50.00 mg

Singapúr - enska - HSA (Health Sciences Authority)

orient europharma pte ltd - lacosamide - infusion, solution - 10.00 mg

Evrópusambandið - enska - EMA (European Medicines Agency)

ucb pharma sa - lacosamide - epilepsy - antiepileptics, - vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - lacosamide - oral solution - 15mg/1ml

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - lacosamide - tablet - 100mg